Summary
Telomeres are the protective structures at the end of eukaryotic chromosomes. Telomerase is a ribonucleoprotein that contains both an RNA and a protein component for the maintenance of telomere length. Telomerase activity is detected in the majority of malignant tumors, but not in normal somatic cells, suggesting that telomerase reactivation is a crucial step in cell immortality and carcinogenesis. The mechanism of how telomerase is activated during tumorigenesis remains unclear. However, the expression of the human telomerase reverse transcriptase (hTERT) gene, which encodes the catalytic protein subunit of human telomerase, has been shown to be the major determining factor. To gain insight into the mechanisms regulating hTERT expression and to facilitate the screening of agents that affect hTERT expression, we have established cell-based systems for monitoring hTERT expression. We linked the hTERT promoter to two different reporter genes encoding green fluorescence protein (GFP) and secreted alkaline phosphatase (SEAP), respectively. These constructs were then transfected into H1299 and hTERT-BJ1 cells. Stable clones harboring these DNA constructs were isolated. In these cells, hTERT expression can be monitored through the quantification of GFP or SEAP activity on an automatic plate reader. Using these systems, we have identified several small molecule compounds that affect the expression of telomerase.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blackburn, E. H. (2005) Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett. 579, 859–862.
Vega, L. R., Mateyak, M. K., Zakian, V. A. (2003) Getting to the end: telomerase access in yeast and humans. Nat. Rev. Mol. Cell. Biol. 4, 948–959.
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., Wu, J. R. (1988) A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. U. S. A. 85, 6622–6626.
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., Shay, J. W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015.
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., Weinberg, R. A. (1999) Creation of human tumour cells with defined genetic elements. Nature 400, 464–468.
Shay, J. W., Wright, W. E. (2002) Telomerase: a target for cancer therapeutics. Cancer Cell 2, 257–265.
Hsu, Y.-H., Lin, J.-J. (2005) Telomere and telomerase as targets for anti-cancer and regeneration therapies. Acta Pharmacol. Sin. 26, 513–518.
Vile, R. G., Hart, I. R. (1993) In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res. 53, 962–967.
Osaki, T., Tanio, Y., Tachibana, I., Hosoe, S., Kumagai, T., Kawase, I., Oikawa, S., Kishimoto, T. (1994) Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res. 54, 5258–5261.
Chen, L., Chen, D., Manome, Y., Dong, Y., Fine, H. A., Kufe, D. W. (1995) Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. J. Clin. Invest. 96, 2775–2782.
Parr, M. J., Manome, Y., Tanaka, T., Wen, P., Kufe, D. W., Kaelin, W. G., Jr., Fine, H. A. (1997) Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat. Med. 3, 1145–1149.
Kyo, S., Inoue, M. (2002) Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene 21, 688–697.
Takakura, M., Kyo, S., Kanaya, T., Hirano, H., Takeda, J., Yutsudo, M., Inoue, M. (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59, 551–557.
Huang, H.-S., Chiou, J.-F., Fong, Y., Hou, C.-C., Lu, Y.-C., Wang, J.-Y., Shih, J.-W., Pan, Y.-R., Lin, J.-J. (2003) Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone. J. Med. Chem. 46, 3300–3307.
Lin, S.-C., Li, W.-C., Shih, J.-W., Hong, K.-F., Pan, Y.-R., Lin, J.-J. (2006) The tea polyphenols EGCG and EGC repress mRNA expression of human telomerase reverse transcriptase (hTERT) in carcinoma cells. Cancer Lett. 236, 80–88.
Huang, H.-S., Chou, C.-L., Guo, C.-L., Yuan, C.-L., Lu, Y.-C., Shieh, F.-Y., Lin, J.-J. (2005) Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones. Bioorg. Med. Chem. 13, 1435–1444.
Denizot, F., Lang, R. (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89, 271–277.
Acknowledgments
The authors thank Yen-Ru Pan, Chen-Yi Wang, and Yu-Cheng Lu for development of the cell-based systems. This work is supported by National Science council grant NSC94-3112-B-010-020 and National Health Research Institute grant NHRI-EX94-9436SI.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Huang, YY., Shih, JW., Lin, JJ. (2007). Establishing Cell-Based Reporter Systems for the Analysis of hTERT Expression. In: Andrews, L.G., Tollefsbol, T.O. (eds) Telomerase Inhibition. Methods in Molecular Biology™, vol 405. Humana Press. https://doi.org/10.1007/978-1-60327-070-0_8
Download citation
DOI: https://doi.org/10.1007/978-1-60327-070-0_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-683-2
Online ISBN: 978-1-60327-070-0
eBook Packages: Springer Protocols